2(R*)-[8-(2,4-dichlorophenyl)-2(S*)-hydroxyoctyl]-2-hydroxybutanedioic acid

  • June 21, 2020
  • By: echemhub

Atherosclerosis Therapy; Treatment of Lipoprotein Disorders; ATP Citrate Lyase Inhibitors